You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 292 No. 13, October 6, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Oncology
 •Cervical Cancer
 •Women's Health
 •Women's Health, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cervical Cancer Screening Among Women Without a Cervix

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Drs Sirovich and Welch1 report that approximately 10 million US women, or almost half of those who have undergone a hysterectomy and therefore have no cervix, are undergoing Pap smear screening for cancer of the cervix. They have brought attention to a procedure that is unnecessary in women who are no longer at risk of cervical cancer. Vaginal cancer is so rare that there is virtually no secondary benefit of cytologic screening in these women. Thus, either patients or the US health care system incurs costs for unnecessary screening: conventional Pap smears cost $15 and new, more sensitive screening methods such as liquid-based cytology ($28 per test) and human papillomavirus (HPV) testing ($48.50 per test) are even more expensive.2 Eliminating Pap smear screening in these women would be cost-effective.

It is noteworthy that the absence of a cervix does not preclude women who have undergone hysterectomy from . . . [Full Text of this Article]

Philip Castle, PhD, MPH
castlep@mail.nih.gov
Division of Cancer Epidemiology and Genetics
National Cancer Institute
Bethesda, Md



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Cervical Cancer Screening Among Women Without a Cervix
Vani Dandolu and Oz Harmanli
JAMA. 2004;292(13):1550.
EXTRACT | FULL TEXT  

Cervical Cancer Screening Among Women Without a Cervix
Clay W. Richardson
JAMA. 2004;292(13):1551.
EXTRACT | FULL TEXT  

Cervical Cancer Screening Among Women Without a Cervix
Mona Saraiya and George F. Sawaya
JAMA. 2004;292(13):1551.
EXTRACT | FULL TEXT  

Cervical Cancer Screening Among Women Without a Cervix—Reply
Brenda Sirovich and H. Gilbert Welch
JAMA. 2004;292(13):1551-1552.
EXTRACT | FULL TEXT  

Cervical Cancer Screening Among Women Without a Cervix
Brenda E. Sirovich and H. Gilbert Welch
JAMA. 2004;291(24):2990-2993.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.